Home › Cholesterol › Illinois › Chicago
Cholesterol clinical trials in Chicago, IL
3 studies for Cholesterol are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- University of Illinois Chicago, Chicago
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
- Research Site, Chicago
- Research Site, Chicago
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
RecruitingPhase 2
- Great Lakes Clinical Trials, Chicago
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC7 studies
- Hialeah, FL6 studies
- Jacksonville, FL5 studies
- Richmond, VA4 studies
- Houston, TX4 studies
- Deltona, FL4 studies
- St. Louis, MO3 studies
- Salt Lake City, UT3 studies
- San Francisco, CA3 studies
- Anderson, SC3 studies
- Winston-Salem, NC3 studies
- Wichita, KS3 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.